Semaglutide Improves Kidney Outcomes in Type 2 Diabetes

from TheBrief.Health · host TheBrief.Health

FLOW demonstrated that semaglutide reduced kidney and cardiovascular risks in high-risk adults with type 2 diabetes and albuminuric CKD, supporting broader kidney-protective therapy.

Episode metadata supplied by the publisher feed · Published Aug 14, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Semaglutide Improves Kidney Outcomes in Type 2 Diabetes

0:00 2:13

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 2 minutes long.

When was this TheBrief.Health episode published?

This episode was published on August 14, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!